Literature DB >> 19026996

The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival.

Hyoung-gon Lee1, Xiongwei Zhu, Gemma Casadesus, Mercé Pallàs, Antoni Camins, Michael J O'Neill, Shigetada Nakanishi, George Perry, Mark A Smith.   

Abstract

In earlier studies, we found profound alterations in specific signal transduction pathways such as mitogen-activated protein kinase signal pathway that mirrored neuronal cell death in Alzheimer disease (AD). To further delineate the mechanism(s) involved in such aberrant signaling, we subsequently showed that mGluR2 is increased in pyramidal neurons in the hippocampus of AD and often co-localizes with neurofibrillary pathology. Based on these data, we suggested that selective neuronal degeneration in AD may arise through the differential expression and activation of specific receptor populations, such as, mGluR2. In this study, to examine the mechanistic relevance of the above-mentioned in vivo findings, we used cell culture models to show that the activation of mGluR2 leads to the activation of extracellular signal-related kinase (ERK) pathways. Importantly, attesting to the in vivo significance of our findings, this pro-survival signaling pathway is also found to be ectopically activated in AD. We also found that the activation of mGluR2 increases the phosphorylation of tau and that the specific activation of mGluR2 reduces oxidative stress mediated cytotoxicity in neuronal cells. Taken together our findings strongly suggest that mGluR2 may participate in mediating the survival of neurons in the face of selective neuronal dysfunction and degeneration in AD. Additionally, our findings lend support to the notion that tau phosphorylation is a neuroprotective antioxidant response to cellular insults.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026996      PMCID: PMC2698437          DOI: 10.1016/j.brainres.2008.10.055

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  42 in total

1.  Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation.

Authors:  Adam D Cash; Gjumrakch Aliev; Sandra L Siedlak; Akihiko Nunomura; Hisashi Fujioka; Xiongwei Zhu; Arun K Raina; Harry V Vinters; Massimo Tabaton; Anne B Johnson; Manuel Paula-Barbosa; Jesus Avíla; Paul K Jones; Rudy J Castellani; Mark A Smith; George Perry
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

2.  Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.

Authors:  X Zhu; R J Castellani; A Takeda; A Nunomura; C S Atwood; G Perry; M A Smith
Journal:  Mech Ageing Dev       Date:  2001-12       Impact factor: 5.432

3.  Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction.

Authors:  E R Matarredona; M Santiago; J L Venero; J Cano; A Machado
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

Review 4.  Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs.

Authors:  V Bruno; G Battaglia; A Copani; M D'Onofrio; P Di Iorio; A De Blasi; D Melchiorri; P J Flor; F Nicoletti
Journal:  J Cereb Blood Flow Metab       Date:  2001-09       Impact factor: 6.200

Review 5.  The role of metabotropic glutamate receptors in Alzheimer's disease.

Authors:  Hyoung-gon Lee; Xiongwei Zhu; Michael J O'Neill; Kate Webber; Gemma Casadesus; Michael Marlatt; Arun K Raina; George Perry; Mark A Smith
Journal:  Acta Neurobiol Exp (Wars)       Date:  2004       Impact factor: 1.579

6.  Phosphorylation of tau at THR212 and SER214 in human neuronal and glial cultures: the role of AKT.

Authors:  H Kyoung Pyo; E Lovati; G M Pasinetti; H Ksiezak-Reding
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

7.  Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease.

Authors:  Hyoung-gon Lee; Osamu Ogawa; Xiongwei Zhu; Michael J O'Neill; Robert B Petersen; Rudolph J Castellani; Hossein Ghanbari; George Perry; Mark A Smith
Journal:  Acta Neuropathol       Date:  2004-02-11       Impact factor: 17.088

Review 8.  The role of mitogen-activated protein kinase pathways in Alzheimer's disease.

Authors:  Xiongwei Zhu; Hyoung-gon Lee; Arun K Raina; George Perry; Mark A Smith
Journal:  Neurosignals       Date:  2002 Sep-Oct

Review 9.  Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain.

Authors:  Mark A Smith; Gemma Casadesus; James A Joseph; George Perry
Journal:  Free Radic Biol Med       Date:  2002-11-01       Impact factor: 7.376

10.  Distribution, levels, and activation of MEK1 in Alzheimer's disease.

Authors:  Xiongwei Zhu; Zheng Sun; Hyoung-gon Lee; Sandra L Siedlak; George Perry; Mark A Smith
Journal:  J Neurochem       Date:  2003-07       Impact factor: 5.372

View more
  13 in total

1.  Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals.

Authors:  Soong Ho Kim; Paul E Fraser; David Westaway; Peter H St George-Hyslop; Michelle E Ehrlich; Sam Gandy
Journal:  J Neurosci       Date:  2010-03-17       Impact factor: 6.167

2.  Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability.

Authors:  Bin He; Sylvia E Perez; Sang H Lee; Stephen D Ginsberg; Michael Malek-Ahmadi; Elliott J Mufson
Journal:  J Comp Neurol       Date:  2020-05-05       Impact factor: 3.215

3.  Presynaptic inhibition upon CB1 or mGlu2/3 receptor activation requires ERK/MAPK phosphorylation of Munc18-1.

Authors:  Sabine K Schmitz; Cillian King; Christian Kortleven; Vincent Huson; Tim Kroon; Josta T Kevenaar; Desiree Schut; Ingrid Saarloos; Joost P Hoetjes; Heidi de Wit; Oliver Stiedl; Sabine Spijker; Ka Wan Li; Huibert D Mansvelder; August B Smit; Lennart Niels Cornelisse; Matthijs Verhage; Ruud F Toonen
Journal:  EMBO J       Date:  2016-04-07       Impact factor: 11.598

4.  Attenuation of Glutamate-Induced Excitotoxicity by Withanolide-A in Neuron-Like Cells: Role for PI3K/Akt/MAPK Signaling Pathway.

Authors:  Nawab John Dar; Naresh Kumar Satti; Prabhu Dutt; Abid Hamid; Muzamil Ahmad
Journal:  Mol Neurobiol       Date:  2017-04-26       Impact factor: 5.590

5.  Down-regulation of serum gonadotropins but not estrogen replacement improves cognition in aged-ovariectomized 3xTg AD female mice.

Authors:  Russell Palm; Jaewon Chang; Jeffrey Blair; Yoelvis Garcia-Mesa; Hyoung-Gon Lee; Rudy J Castellani; Mark A Smith; Xiongwei Zhu; Gemma Casadesus
Journal:  J Neurochem       Date:  2014-04-02       Impact factor: 5.372

Review 6.  The role of G protein-coupled receptors in the pathology of Alzheimer's disease.

Authors:  Amantha Thathiah; Bart De Strooper
Journal:  Nat Rev Neurosci       Date:  2011-02       Impact factor: 34.870

Review 7.  Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases.

Authors:  Xiao-xia Dong; Yan Wang; Zheng-hong Qin
Journal:  Acta Pharmacol Sin       Date:  2009-04       Impact factor: 6.150

8.  Group II metabotropic glutamate receptor agonist LY379268 regulates AMPA receptor trafficking in prefrontal cortical neurons.

Authors:  Min-Juan Wang; Yan-Chun Li; Melissa A Snyder; Huaixing Wang; Feng Li; Wen-Jun Gao
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

9.  Therapeutic potential of metabotropic glutamate receptor modulators.

Authors:  N Hovelsø; F Sotty; L P Montezinho; P S Pinheiro; K F Herrik; A Mørk
Journal:  Curr Neuropharmacol       Date:  2012-03       Impact factor: 7.363

Review 10.  G Protein-Coupled Receptors (GPCRs) in Alzheimer's Disease: A Focus on BACE1 Related GPCRs.

Authors:  Juan Zhao; Yulin Deng; Zhaotan Jiang; Hong Qing
Journal:  Front Aging Neurosci       Date:  2016-03-24       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.